成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國籍:中國
網(wǎng)址: http://www.efebio.com
產(chǎn)品總數(shù):11974
87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產(chǎn)品列表

Talastine 他拉斯汀 16188-61-7
UCM-13207 化合物 UCM-13207 1621536-10-4
(R)-AZD 9639 化合物 (R)-AZD 9639 1646857-28-4
Isolupalbigenin ISOLUPALBIGENIN 162616-70-8
AC 7739 化合物 AC 7739 162705-22-8
JG-231 JG-231 1627126-59-3
Karavilagenin F Karavilagenin F 1639024-15-9
Aprutumab 阿普盧妥單抗 1634620-63-5
BTA-9881 化合物 T26914 1646857-24-0
UniPR129 化合物 T26310 1639159-47-9
Delmetacin 地美辛 16401-80-2
Inotuzumab 英妥珠單抗 1660159-36-3
GBT1118 化合物 GBT1118 1628799-51-8
Zilovertamab 澤羅妥單抗 1643432-38-5
Leramistat HMC-C-01-A|||MBS2320 1642602-54-7
Itacnosertib N4-([2,2-bipyridin]-3-yl)-N2-(3-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-2,4-diamine 1628870-27-8
CRT-0105950 CRT-0105950 (CRT0105950) 1661845-86-8
TL4-12 化合物 T26280 1620820-12-3
Ralaniten triacetate RALANITEN TRIACETATE 1637573-04-6
Ranevetmab Ranevetmab 1632282-27-9
Tavolixizumab Tavolimab 1635395-25-3
Honokiol DCA Acetic acid, 2,2-dichloro-, 2'-[(2,2-dichloroacetyl)oxy]-3,5'-di-2-propen-1-yl[1,1'-biphenyl]-4-yl ester 1620160-42-0
Gü2602 化合物 Gü2602 1627094-88-5
(Rac)-Telinavir 化合物 (RAC)-TELINAVIR 162679-88-1
MAO-B-IN-8 化合物 MAO-B-IN-8 1638956-60-1
GNE-8505 GNE-8505 1620573-48-9
KZR-504 KZR-504 1629052-78-3
TASP0390325 2-(3-Chloro-4-fluorophenyl)-N-(1-methylethyl)-6-[3-(4-morpholinyl)propoxy]-4-oxo-pyrido[2,3-d]pyrimidine-3(4H)-acetamide hydrochloride 1642187-96-9
(R)-DNMDP (R)-DNMDP 1630760-60-9
Ladiratuzumab LADIRATUZUMAB (ANTI-SLC39A6) 1629760-28-6
TDRL-551 化合物 T28935 1644626-43-6
TAK-020 化合物TAK-020 1627603-21-7
Zectivimod ZECTIVIMOD 1623066-63-6
Talviraline HBY 097 163451-80-7
Parthenosin b-D-Glucopyranosiduronic acid,2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl, butyl ester 166196-16-3
SLMP53-1 化合物 SLMP53-1 1643469-17-3
Naratuximab 那妥昔單抗 1622327-39-2
Vonlerolizumab Vonlerolizumab 1638935-72-4
Flotetuzumab Flotetuzumab 1664355-28-5
Suvratoxumab Suvratoxumab 1629620-18-3
Tomuzotuximab Tomuzotuximab 1646321-00-7
HTL14242 Benzonitrile, 3-chloro-5-[6-(5-fluoro-2-pyridinyl)-4-pyrimidinyl]- 1644645-32-8
MLK-IN-1 N-(3,4-二甲氧基苯基)-3-(7-甲氧基苯并[B]噻吩-2-基)咪唑并[1,2-B]噠嗪-6-胺 1627729-62-7
Fluoroethylnormemantine hydrochloride FLUOROETHYLNORMEMANTINE HYDROCHLORIDE 1639210-25-5
(Rac)-Naxifylline NAXIFYLLINE異構體 166181-76-6
Dalzanemdor 化合物 DALZANEMDOR 1629853-48-0
pan-HER-IN-2 化合物 PAN-HER-IN-2 1639040-95-1
hTYR/AbTYR-IN-1 HTYR/ABTYR抑制劑1 1625821-37-5
BDBM50597431 化合物BDBM50597431 1629853-49-1
Nerelimomab Nerelimomab [usan:inn] 162774-06-3
Dapson-13C12 氨苯砜(13C12) 1632119-29-9
NDB NDB 1660153-08-1
ALDH2 modulator 1 ALDH2調節(jié)劑1 1629615-99-1
Selicrelumab 塞魯單抗 1622140-49-1
Fluoroethylnormemantine FLUOROETHYLNORMEMANTINE 1639210-26-6
ZEN-3694 ZEN 3694 1643947-30-1
Clivatuzumab 克利妥珠單抗 1622075-09-5
3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride 3-(哌啶-4-基)苯并[D]噁唑-2(3H)-酮鹽酸鹽 162045-54-7
Rivabazumab Rivabazumab 1627519-84-9
Suptavumab Suptavumab 1629615-23-1
Lupartumab Lupartumab 1640971-88-5
Relatlimab Relatlimab 1673516-98-7
PW0464 PW0464 1643462-93-4
(Rac)-MEM 1003 3,5-Pyridinedicarboxylic acid, 4-(2-chloro-3-cyanophenyl)-1,4-dihydro-2,6-dimethyl-, 3-(2-methoxyethyl) 5-(1-methylethyl) ester 165187-25-7
AGN 192870 化合物 AGN 192870 166977-57-7
Azido-PEG3-C6-Cl 疊氮-三聚乙二醇-C6-氯 1625717-44-3
BrBzGCp2 S-4-bromobenzylglutathione cyclopentyl diester 166038-00-2
L-372662 化合物 T32497 162045-26-3
VU0453379 VU0453379 1638646-27-1
PDK1-IN-RS2 PDK1-IN-RS2 1643958-89-7
Timigutuzumab Timigutuzumab 1665274-14-5
Cipepofol 化合物 T32105 1637741-58-2
Nav1.8-IN-4 2-(4-氟-2-甲基苯氧基)-N-(2-氧代-1,2-二氫吡啶-4-基)-4-(三氟甲基)苯甲酰胺 1620846-16-3
DA-6886 1645260-76-9 1645260-76-9
Glycopyrronium tosylate 格隆銨甲苯磺酸鹽 1624259-25-1
GPR81 agonist 1 化合物 GPR81 AGONIST 1 1620992-67-7
GS-626510 GS-626510 1637770-13-8
Laprituximab Laprituximab 1622327-38-1
Frovocimab Frovocimab 1643672-70-1
ACT-660602 化合物 ACT-660602 1646267-59-5
DHODH-IN-17 化合物 DHODH-IN-17 16344-26-6
Eptinezumab 依普奈珠單抗 1644539-04-7
Fremanezumab 瑞瑪奈珠單抗 1655501-53-3
Enrasentan 1H-Indene-2-carboxylicacid,1-(1,3-benzodioxol-5-yl)-2,3-dihydro-3-[2-(2-hydroxyethoxy)-4-methoxyphenyl]-5-propoxy-,(1S,2R,3S)- 167256-08-8
Otilimab 對照抗體 1638332-55-4
Navicixizumab Navicixizumab 1638338-43-8
TGP-377/421 化合物 TGP-377/421 16752-89-9
Vobarilizumab Vobarilizumab 1628814-88-9
FD-IN-1 FD-IN-1 1646682-14-5
Gimsilumab 瑾司魯單抗 1648796-29-5
CPL304110 化合物 CPL304110 1627826-19-0
RS1-PDK1 inhibitor N-(6-chloro-1,3-benzothiazol-2-yl)-1-benzothiophene-3-sulfonamide 1643958-85-3
URAT1 inhibitor 7 URAT1 INHIBITOR 7 1632002-28-8
Ibiglustat succinate IBIGLUSTAT SUCCINATE 1629063-80-4
ABI-1968 1626364-18-8 1626364-18-8
CT-2584 1H-Purine-2,6-dione, 1-[11-(dodecylamino)-10-hydroxyundecyl]-3,7-dihydro-3,7-dimethyl- 166981-13-1
Osimertinib-d6 奧希替尼雜質28 1638281-44-3
DI-82 DI-82 1638148-50-1
Elsubrutinib ELSUBRUTINIB 1643570-24-4
FGFR4-IN-5 FGFR4-IN-5 1628793-01-0
87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007? ChemicalBook. All rights reserved.